The glycoconjugate chain determines the characteristics of the cell, and the presence of abnormal glycoconjugate chain in the body is associated with the division of cancer cells, so the glycoconjugate antigen test has some significance for cancer diagnosis, and a high glycoconjugate antigen found during the test should be combined with other ancillary tests to help with the diagnosis.
Some people have high glycoconjugate antigen 724, which is more likely to be found in the bodies of patients with cancers of the digestive tract, such as gastric cancer, lung cancer, ovarian cancer, and pancreatic cancer, but inflammation in the digestive tract can also cause high glycoconjugate antigen 724.
High glycoantigen 199 is associated with pancreatic cancer and gallbladder cancer, but some patients also have varying degrees of high levels due to pancreatitis, cholecystitis, hepatitis, and other diseases.
Patients with pancreatic cancer and colon cancer will find high glycoconjugate antigen 242 when they are tested, and many will also have high levels due to colitis and pancreatitis.
Elevated glycoconjugate antigen 125 is associated with ovarian, fallopian tube, and cervical cancer, and some gynecologic inflammatory conditions can also cause high glycoconjugate antigen 125.
Because inflammation can cause high glycoconjugate antigen, high glycoconjugate antigen has no absolute value in the diagnosis of cancer, but only a reference value, and needs to be combined with gastroscopy, colonoscopy, and CT examination to confirm the diagnosis.